Certain ultrasound features are associated with an increased risk of thyroid malignancy. However, they were studied mainly in papillary thyroid cancers (PTCs); these results cannot be simply extrapolated for the differentiation of follicular thyroid adenomas and cancers (FTAs and FTCs). The aim of our study was to perform a meta-analysis to identify sonographic features sug-gesting malignancy in the case of follicular lesions, potentially differentiating FTA and FTC. We searched thirteen databases from January 2006 to December 2020 to find all relevant, full-text jour-nal articles written in English. Analyses assessed the accuracy of malignancy detection in case of follicular lesions, potentially differentiating FTA and FTC included the odds ratio (OR), sensitivity, specificity, positive and negative predictive values. A random-effects model was used to summarize collected data. Twenty studies describing sonographic features of 10,215 nodules met the inclusion criteria. The highest overall ORs to increase the risk of malignancy were calculated for tumor protrusion (OR = 10.19; 95% confidence interval: 2.62–39.71), microcalcifications or mixed type of calcifications (coexisting micro and macrocalcifications): 6.09 (3.22–11.50), irregular margins: 5.11 (2.90– 8.99), marked hypoechogenicity: 4.59 (3.23–6.54), and irregular shape: 3.6 (1.19–10.92). The most crucial feature associated with an increased risk of FTC is capsule protrusion, followed by the presence of calcifications, irrespectively of their type.

Follicular lesion of unknown signifi-cance, Follicular neoplasm, Follicular thyroid cancer, Thyroid, Ultrasonography
dx.doi.org/10.3390/cancers13050938, hdl.handle.net/1765/135122
Department of Radiology

Borowczyk, M. (Martyna), Woliński, K. (Kosma), Więckowska, B. (Barbara), Jodłowska-Siewert, E. (Elżbieta), Szczepanek-Parulska, E. (Ewelina), Verburg, F.A, & Ruchała, M. (Marek). (2021). Sonographic features differentiating follicular thyroid cancer from follicular adenoma–a meta-analysis. Cancers, 13(5), 1–16. doi:10.3390/cancers13050938